PubRank

Alan Wu

Author PubWeight™ 52.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 21.55
2 Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003 2.20
3 Stability of active ingredients in long-expired prescription medications. Arch Intern Med 2012 2.08
4 Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003 1.81
5 Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem 2003 1.67
6 The spectrum of severe acute respiratory syndrome-associated coronavirus infection. Ann Intern Med 2004 1.51
7 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta 2012 1.51
8 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion 2012 1.50
9 Laboratory diagnosis of SARS. Emerg Infect Dis 2004 1.41
10 Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology 2003 1.26
11 Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003 1.20
12 Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol 2004 1.18
13 Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis 2004 1.09
14 Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003 1.09
15 Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology 2003 1.07
16 Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. Clin Infect Dis 2004 0.97
17 FieldML, a proposed open standard for the Physiome project for mathematical model representation. Med Biol Eng Comput 2013 0.95
18 Clinical significance of hepatic derangement in severe acute respiratory syndrome. World J Gastroenterol 2005 0.89
19 Human metapneumovirus-associated atypical pneumonia and SARS. Emerg Infect Dis 2004 0.86
20 Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features. Radiology 2004 0.80
21 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem Lab Med 2012 0.80
22 Retrospective analysis of liver function derangement in severe acute respiratory syndrome. Am J Med 2004 0.79
23 Mass spectrometry in the clinical laboratory: how have we done, and where do we need to be? Clin Chem 2009 0.78
24 Diagnostic criteria during SARS outbreak in Hong Kong. Emerg Infect Dis 2004 0.78
25 Severe acute respiratory syndrome: thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period. J Comput Assist Tomogr 2004 0.77
26 Marathoner's heart? Circulation 2006 0.77
27 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Scand J Clin Lab Invest 2012 0.75
28 Imaging of severe acute respiratory syndrome in Hong Kong. AJR Am J Roentgenol 2003 0.75
29 Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Transfusion 2010 0.75
30 Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites. Bioanalysis 2011 0.75
31 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Biochem 2012 0.75
32 Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Scand J Clin Lab Invest 2010 0.75
33 Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Clin Chem 2010 0.75
34 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem 2012 0.75
35 Full-disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors. Am J Hematol 2011 0.75
36 Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Clin Chem Lab Med 2010 0.75
37 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Statement by the Consortium of Laboratory Medicine Journal Editors. Ann Clin Biochem 2012 0.75
38 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Am J Hematol 2012 0.75
39 Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Ann Clin Biochem 2011 0.75